We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.7B
AUM Growth
+$567M
(+2.6%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-6.31%
Top 10 Holdings %
Top 10 Hldgs %
30.36%
Holding
1,757
New
185
Increased
417
Reduced
837
Closed
239
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Everest Group
EG
|
+$100M |
| 2 |
Take-Two Interactive
TTWO
|
+$82.9M |
| 3 |
United Parcel Service
UPS
|
+$82.8M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$67.7M |
| 5 |
EA
Electronic Arts
EA
|
+$66.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$166M |
| 2 |
HCA Healthcare
HCA
|
+$101M |
| 3 |
Alibaba
BABA
|
+$82.1M |
| 4 |
Monster Beverage
MNST
|
+$76.7M |
| 5 |
ResMed
RMD
|
+$70.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Consumer Discretionary | 14.12% |
| 3 | Communication Services | 13.21% |
| 4 | Financials | 12.25% |
| 5 | Healthcare | 11.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Alphatec Holdings
ATEC
$1.48B
| $158K | ﹤0.01% |
10,330
-2,842
| -22% | -$43.8K |
|
1502
Curis
CRIS
$3.53M
| $155K | ﹤0.01% |
+48
| New | +$217K |
|
1503
BGC Group
BGC
$5.1B
| $152K | ﹤0.01% |
26,772
| – | – |
|
|
OPTN
1504
DELISTED
OptiNose
OPTN
| $146K | ﹤0.01% |
3,138
-180
| -5% | -$9.19K |
|
1505
Fortress Biotech
FBIO
$92.7M
| $126K | ﹤0.01% |
2,353
-146
| -6% | -$8.81K |
|
1506
Clear Channel Outdoor Holdings
CCO
$1.2B
| $121K | ﹤0.01% |
+45,670
| New | +$110K |
|
1507
Abeona Therapeutics
ABEO
$368M
| $120K | ﹤0.01% |
3,087
-15,354
| -83% | -$626K |
|
1508
Stereotaxis
STXS
$138M
| $117K | ﹤0.01% |
12,150
-20
| -0.2% | -$158 |
|
1509
Minerva Neurosciences
NERV
$189M
| $116K | ﹤0.01% |
6,243
-17,149
| -73% | -$369K |
|
|
RRD
1510
DELISTED
RR Donnelley & Sons Co.
RRD
| $114K | ﹤0.01% |
+18,230
| New | +$99.4K |
|
1511
Ovid Therapeutics
OVID
$517M
| $111K | ﹤0.01% |
28,360
-4,500
| -14% | -$17.8K |
|
|
LITS
1512
Lite Strategy Inc
LITS
$30.4M
| $106K | ﹤0.01% |
1,860
-100
| -5% | -$6.42K |
|
|
SCPX
1513
DELISTED
Scorpius Holdings, Inc.
SCPX
| $96K | ﹤0.01% |
4
| – | – |
|
|
EGIO
1514
DELISTED
Edgio, Inc. Common Stock
EGIO
| $92K | ﹤0.01% |
732
-512
| -41% | -$67.6K |
|
1515
Alto Ingredients
ALTO
$327M
| $79K | ﹤0.01% |
+12,961
| New | +$75.4K |
|
1516
ADMA Biologics
ADMA
$2.11B
| $59K | ﹤0.01% |
37,165
-2,100
| -5% | -$3.69K |
|
1517
Cartesian Therapeutics
RNAC
$267M
| $45K | ﹤0.01% |
+359
| New | +$42.8K |
|
1518
Verastem
VSTM
$615M
| $45K | ﹤0.01% |
930
-5,470
| -85% | -$228K |
|
1519
Acadia Pharmaceuticals
ACAD
$4.99B
| – | – |
-16,458
| Closed | -$425K |
|
|
ADVM
1520
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-2,138
| Closed | -$211K |
|
1521
Assured Guaranty
AGO
$3.32B
| – | – |
-22,497
| Closed | -$951K |
|
1522
Agilysys
AGYS
$3.05B
| – | – |
-8,005
| Closed | -$384K |
|
1523
Albany International
AIN
$1.81B
| – | – |
-2,830
| Closed | -$236K |
|
1524
Assurant
AIZ
$13.9B
| – | – |
-7,687
| Closed | -$1.09M |
|
1525
Allegiant Air
ALGT
$2.4B
| – | – |
-1,213
| Closed | -$296K |
|
Similar funds
FDCDDQ
TWC
WP
N
PCH
VAI
Los Angeles Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Los Angeles Capital Management held 1,757 positions worth $22.7B, up 2.6% from $22.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Los Angeles Capital Management withdrew a net $1.43B in Q2 2021, closing 239 positions and reducing 837 holdings. Its most notable exit was Alibaba, an estimated $82.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Los Angeles Capital Management opened a new position in Ulta Beauty worth $35.5M.
- Los Angeles Capital Management's largest Q2 2021 buy was Ulta Beauty: 102,538 shares worth $35.5M.
- Los Angeles Capital Management added most to Everest Group in Q2 2021, an estimated $100M increase.
- Los Angeles Capital Management's biggest Q2 2021 reduction was Procter & Gamble, cutting an estimated $166M.
- Los Angeles Capital Management fully exited Alibaba in Q2 2021, selling an estimated $82.1M.
- Los Angeles Capital Management's ten largest holdings make up 30% of its $22.7B portfolio in Q2 2021.
- Los Angeles Capital Management opened 185 new positions and closed 239 in Q2 2021.
- Los Angeles Capital Management's portfolio value rose 2.6% quarter-over-quarter to $22.7B.
Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.